Dabigatran Etexilate Mesylate

규격

872728-81-9CAS 번호

828-727-6EC 번호

ethyl 3-[[2-[[4-(N-hexoxycarbonylcarbamimidoyl)anilino]methyl]-1-methylbenzimidazole-5-carbonyl]-pyridin-2-ylamino]propanoate;methanesulfonic acidIUPAC 명칭

C35H45N7O8S화학식

723.8 g/mol분자량

Dabigatran etexilate mesylate; 872728-81-9; Dabigatran etexilate mesilate; Pradaxa; BIBR 1048 MS; SC7NUW5IIT; Dabigatran etexilate methanesulfonate; BIBR 1048MS; BIBR-1048-MS; PRADAXA (DABIGATRAN ETEXILATE MESYLATE); Ethyl 3-(((2-(((4-(((hexyloxy)carbonyl)carbamimidoyl)phenyl)amino)methyl)-1-methyl-1h-benzimidazol-5-yl)carbonyl)(pyridin-2-yl)amino)propanoate, methanesulfonate; beta-Alanine, N-((2-(((4-((((hexyloxy)carbonyl)amino)iminomethyl)phenyl)amino)methyl)-1-methyl-1h-benzimidazol-5-yl)carbonyl)-N-2-pyridinyl-, ethyl ester, methanesulfonate; 593282-20-3; CHEBI:70743; DTXSID20236248; RefChem:54925; DTXCID20158739; Beta-alanine, N-((2-(((4-((((hexyloxy)carbonyl)amino)iminomethyl) phenyl)amino)methyl)-1-methyl-1H-benzimidazol-5-yl)carbonyl)-N-2-pyridinyl-,ethyl ester, methanesulfonate; Pradaxa mesylate; Dabigatran etexilate (mesylate); Dabigatran etexilate mesylate [USAN]; Dabigatran etexilate mesylate (USAN); Ethyl 3-(2-(((4-(N-((hexyloxy)carbonyl)carbamimidoyl)phenyl)amino)methyl)-1-methyl-N-(pyridin-2-yl)-1H-benzo[d]imidazole-5-carboxamido)propanoate methanesulfonate; ethyl 3-[[2-[[4-(N-hexoxycarbonylcarbamimidoyl)anilino]methyl]-1-methylbenzimidazole-5-carbonyl]-pyridin-2-ylamino]propanoate;methanesulfonic acid; UNII-SC7NUW5IIT; orb1302061; SCHEMBL1268805; CHEMBL1615369; SCHEMBL28563773; SCHEMBL29354679; SCHEMBL30487097; GLXC-08118; HMS5087O09; HY-10274AR; [14C]-Dabigatran etexilate mesylate; EBC-12905; HY-10274A; AKOS015951091; CS-1398; FD20773; SB19226; AC-26434; DABIGATRAN ETEXILATE (AS MESILATE); Dabigatran etexilate (mesylate) (Standard); DB-072628; Dabigatran etexilate mesilate [EP monograph]; DABIGATRAN ETEXILATE MESILATE [MART.]; T5133; (Z)-ethyl 3-(2-(((4-(N'-((hexyloxy)carbonyl)carbamimidoyl)phenyl)amino)methyl)-1-methyl-N-(pyridin-2-yl)-1H-benzo[d]imidazole-5-carboxamido)propanoate methanesulfonate; DABIGATRAN ETEXILATE MESILATE [WHO-DD]; D07082; DABIGATRAN ETEXILATE MESILATE [EMA EPAR]; DABIGATRAN ETEXILATE MESYLATE [ORANGE BOOK]; EN300-20384744; N-[[2-[[[4-[[[(hexyloxy)carbonyl]amino]iminomethy; Q27139056; Dabigatran Etexilate Mesylate Working Standard (Secondary Reference Standard); .BETA.-ALANINE, N-((2-(((4-((((HEXYLOXY)CARBONYL)AMINO)IMINOMETHYL)PHENYL)AMINO)METHYL)-1-METHYL-1H-BENZIMIDAZOL-5-YL)CARBONYL)-N-2-PYRIDINYL-, ETHYL ESTER, METHANESULFONATE; .BETA.-ALANINE, N-((2-(((4-((((HEXYLOXY)CARBONYL)AMINO)IMINOMETHYL)PHENYL)AMINO)METHYL)-1-METHYL-1H-BENZIMIDAZOL-5-YL)CARBONYL)-N-2-PYRIDINYL-, ETHYL ESTER, METHANESULFONATE (1:1); .BETA.-ALANINE, N-((2-(((4-((((HEXYLOXY)CARBONYL)AMINO)IMINOMETHYL)PHENYL)AMINO)METHYL)-1-METHYL-1H-BENZIMIDAZOL-5-YL)CARBONYL)-N-2-PYRIDINYL-, ETHYL ESTER, METHANESULPHONATE; .BETA.-ALANINE, N-((2-(((4-((((HEXYLOXY)CARBONYL)AMINO)IMINOMETHYL)PHENYL)AMINO)METHYL)-1-METHYL-1H-BENZIMIDAZOL-5-YL)CARBONYL)-N-2-PYRIDINYL-, ETHYL ESTER, METHANESULPHONATE (1:1); BIBR 1048;BIBR-1048;Prazaxa;ethyl 3-(2-(((4-(N-((hexyloxy)carbonyl)carbamimidoyl)phenyl)amino)methyl)-1-methyl-N-(pyridin-2-yl)-1H-benzo[d]imidazole-5-carboxamido)propanoate methanesulfonate; ETHYL 3-(((2-(((4-(((HEXYLOXY)CARBONYL)CARBAMIMIDOYL)PHENYL)AMINO)METHYL)-1-METHYL-1H-BENZIMIDAZOL-5-YL)CARBONYL)(PYRIDIN-2-YL)AMINO)PROPANOATE, METHANESULPHONATE; ethyl 3-[[2-[[4-[(E)-N'-hexoxycarbonylcarbamimidoyl]anilino]methyl]-1-methyl-benzimidazole-5-carbonyl]-(2-pyridyl)amino]propanoate;methanesulfonic acid; ethyl 3-{1-[2-({[4-({[(hexyloxy)carbonyl]amino}methanimidoyl)phenyl]amino}methyl)-1-methyl-1H-1,3-benzodiazol-5-yl]-N-(pyridin-2-yl)formamido}propanoate; methanesulfonic acid; N-[[2-[[[4-[[[(Hexyloxy)carbonyl]aMino]iMinoMethyl]phenyl]aMino]Methyl]-1-Methyl-1H-benziMidazol-5-y; N-[[2-[[[4-[[[(Hexyloxy)carbonyl]amino]iminomethyl]phenyl]amino]methyl]-1-methyl-1H-benzimidazol-5-yl]carbonyl]-N-2-pyridinyl-b-alan ine ethyl ester methanesulfonate동의어